AG真人官方

Credo Technology Group Holding Ltd (CRDO) 鈥� Form 4 filing dated 07/08/2025

President & CEO William J. Brennan reported a Rule 16 transaction code 鈥淔鈥�, indicating shares were withheld by the company on 07/05/2025 to cover tax obligations arising from restricted-stock-unit (RSU) vesting. A total of 6,149 ordinary shares were disposed at an accounting price of $93.61 per share (鈮� $575 k in value). Following the transaction, Brennan still owns 439,782 shares directly and 2,211,978 shares indirectly through The Brennan Family Trust, leaving his total beneficial stake at roughly 2.65 million shares.

The filing reflects a routine, non-cash settlement rather than an open-market sale. Ownership concentration by the CEO remains high, signalling continued alignment with common shareholders. No derivative securities were involved and there are no indications of changes in executive roles or other material corporate events.

SciSparc announced that shareholders approved all proposals at their adjourned annual general meeting held on June 26, 2025. The meeting resulted in the approval of two significant documents:

• A new amended and restated articles of association
• An updated compensation policy for executive officers and directors

These approvals were obtained with the requisite majority in accordance with Israeli Companies Law and the company's existing articles of association. The proposals were previously detailed in a proxy statement furnished to the SEC on May 21, 2025.

The Form 6-K filing will be incorporated into multiple company registration statements, including several Form F-3s (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) and Form S-8s (File Nos. 333-278437, 333-225773, 333-286791). The document was signed by Oz Adler, Chief Executive Officer.

SciSparc has filed an amended F-4 registration statement regarding its proposed merger with AutoMax Motors. The merger agreement, initially signed on April 10, 2024, and amended multiple times through May 8, 2025, will result in AutoMax becoming a wholly-owned subsidiary of SciSparc.

Key terms of the merger include:

• AutoMax shareholders and advisor will own approximately 49.99% of SciSparc's share capital post-merger
• SciSparc shareholders will retain approximately 50.01% ownership
• SciSparc will maintain its Nasdaq listing under symbol "SPRC"
• Expected closing in Q3 2025, subject to shareholder and court approvals

A special shareholder meeting is scheduled for August 13, 2025 to vote on: merger approval, new indemnification agreements for directors/officers, executive bonuses contingent on merger closing, and election of new board members. Post-merger, Oz Adler will serve as CEO/CFO, with Dr. Adi Zuloff-Shani as CTO.

SciSparc announced the adjournment of its Annual General Meeting of Shareholders due to lack of quorum on June 25, 2025. The Adjourned Annual Meeting is rescheduled for June 26, 2025, at 8:00 a.m. (Eastern Time) / 3:00 p.m. (Israel time) at the company's Tel Aviv offices.

Key details:

• If quorum is not achieved within 30 minutes of the rescheduled meeting, any number of shareholders present in person, by proxy, or who delivered a proxy card will constitute a quorum
• Previously submitted proxy cards for the original meeting will remain valid for the Adjourned Meeting
• The Form 6-K will be incorporated into multiple registration statements, including Form F-3 and Form S-8 filings

The report was signed by Oz Adler, Chief Executive Officer, on June 25, 2025.

SciSparc Ltd has announced a significant corporate action with a 1-for-21 reverse share split as reported in their Form 6-K filing dated June 28, 2025. This strategic move will consolidate every 21 existing shares into 1 new share.

Key filing details:

• Filing incorporates by reference into multiple registration statements, including Form F-3 (6 filings) and Form S-8 (3 filings)
• Document signed by Oz Adler, who serves as both Chief Executive Officer and Chief Financial Officer
• Company maintains its principal executive offices in Tel Aviv, Israel
• Confirms status as a Form 20-F filer for annual reports

The reverse split announcement suggests a potential strategic effort to meet minimum share price requirements for continued exchange listing or improve the stock's marketability to institutional investors.

SciSparc (Nasdaq: SPRC) filed Amendment No. 2 to its Form F-3 shelf registration, allowing the resale of up to 61,209,538 ordinary shares by existing investors.

The shares consist of (i) 53,617,021 shares issuable upon conversion of $4.2 million in convertible debentures and (ii) 7,592,517 shares issuable upon exercise of warrants. The debenture conversion price equals the lower of a fixed $0.4681 or 95 % of the 20-day VWAP, with a $0.0846 floor; warrants are exercisable at $0.5532. SciSparc will receive no proceeds from share resales, but could receive up to roughly $4.2 million in cash should all warrants be exercised.

The filing reiterates the company鈥檚 strategy of developing cannabinoid-based therapeutics (programs SCI-110 and SCI-210) and summarizes its pending merger with AutoMax Motors, an Israeli vehicle importer. The Merger Agreement has been amended four times (latest on 8 May 2025) and remains subject to shareholder approval.

Key investor considerations include: potential dilution from a share count materially larger than current float, a resale overhang that could pressure the $0.321 market price, and ongoing uncertainty surrounding the AutoMax merger. Risk factors highlight limited U.S. enforceability of judgments against the Israeli company and management, and the clinical-stage nature of operations with IFRS-based financials.